美国卫生和公众服务部透露，包括诺华癌症药物在内的54种处方药的成本节约，Ozenpic可能是下一个-动脉网

US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next

benzinga 等信源发布 2024-10-01 14:51



可切换为仅中文







Monday, the U.S. Department of Health and Human Services (HHS) announced that Medicare enrollees will benefit from reduced prices on 54 drugs through Medicare Part B, effective from October 1, 2024, to December 31, 2024.

周一，美国卫生与公众服务部（HHS）宣布，医疗保险参保者将从2024年10月1日至2024年12月31日期间通过医疗保险B部分的54种药物的降价中受益。

The program aims to counter drug price hikes that exceed inflation, providing financial relief for over 822,000 Medicare beneficiaries who rely on these medications to treat conditions like cancer, osteoporosis, and pneumonia.

该计划旨在应对超过通货膨胀的药品价格上涨，为822000多名医疗保险受益人提供经济救济，这些受益人依靠这些药物治疗癌症、骨质疏松症和肺炎等疾病。

Also Read: Doctors Struggle to Secure Medicare Coverage for Heart Patients on Novo Nordisk’s Wegovy

另请阅读：医生努力确保诺和诺德Wegovy上心脏病患者的医疗保险

HHS Secretary Xavier Becerra emphasized that the Biden administration’s prescription drug policies are making a tangible impact on seniors and people with disabilities by reducing out-of-pocket costs.

卫生和公众服务部部长泽维尔·贝塞拉强调，拜登政府的处方药政策通过降低自付费用，正在对老年人和残疾人产生切实的影响。

According to Chiquita Brooks-LaSure, CMS Administrator, some Medicare beneficiaries could see daily savings ranging from $1 to as much as $3,854 on drugs included in the rebate program.

据CMS管理人奇奎塔·布鲁克斯·拉苏尔（ChiquitaBrooksLasure）称，一些医疗保险受益人可以在退税计划中包含的药物上每天节省1美元至3854美元不等。

For example, a cancer patient using Novartis’ AGs NVS Kymriah could save up to $3,000.

例如，使用诺华AGs NVS Kymriah的癌症患者可以节省多达3000美元。

Brooks-LaSure also noted that the law disincentivizes drug companies from raising prices faster than inflation, which helps protect Medicare beneficiaries from sharp price increases.

布鲁克斯·拉苏尔（Brooks LaSure）还指出，该法律禁止制药公司以高于通货膨胀的速度提价，这有助于保护医疗保险受益人免受价格大幅上涨的影响。

The Inflation Reduction Act’s initiatives extend beyond 2024. In August, the administration reached new agreements to reduce prices for ten additional high-cost drugs.

《降低通货膨胀法案》的倡议将延续到2024年以后。8月，政府达成了新协议，降低了另外10种高成本药物的价格。

Once these prices take effect in 2026, Medicare is projected to save an estimated $6 billion, while beneficiaries could see a reduction of $1.5 billion in out-of-pocket expenses.

一旦这些价格在2026年生效，预计医疗保险将节省约60亿美元，而受益人的自付费用将减少15亿美元。

Starting in 2025, Medicare Part D enrollees will further benefit from a $2,000 annual cap on prescription drug costs, down from the current cap of $3,500 for those with high expenses.

从2025年开始，Medicare D部分的参保者将进一步受益于处方药费用的2000美元年度上限，而目前高费用者的上限为3500美元。

According to some analysts, Novo Nordisk A/S’ NVO blockbuster diabetes drug Ozempic might be included, along with several other well-known medications, in the next round of negotiations, which is set for 2027.

据一些分析人士称，诺和诺德公司（NovoNordisk A/S）的NVO重磅糖尿病药物Ozempic可能会与其他几种知名药物一起参加定于2027年举行的下一轮谈判。